Aehr Test Systems

Vernon Rogers’ recent 10,888‑share sale at $70 a share shows routine portfolio rebalancing amid rising insider activity and a $60 M equity raise—what investors should watch next.

CEO Erickson Gayn’s recent buy‑sell‑buy moves at Aehr Test Systems signal insider confidence amid a rally, yet Q1 earnings may temper the upside – watch for future block trades.

Insider buying at Aehr Test Systems signals executive confidence in R&D‑driven growth; investors should watch upcoming product launches and stock momentum.

Insider selling tops buying at Aehr Test Systems—investors see a cautious rebalance amid strong silicon‑photonics contracts and a rising AI‑cloud niche.

Investor insight: CFO Siu Chris’s recent 821‑share sale at $44.32, balanced by day‑earlier purchases, shows routine liquidity moves, not a confidence drop, amid positive Aehr Test Systems momentum.

CTO insider buying at Aehr Test Systems shows confidence in a sharp bullish rally, offering investors a disciplined stake‑holding strategy and a signal of growth potential.

Executive trades show CEO Erickson Gayn buying at a discount via ESPP and selling for liquidity, suggesting confidence in Aehr Test Systems’ silicon photonics future.

Discover how Aehr Test Systems’ COO’s ESPP buys signal management confidence in the company’s silicon photonics growth, boosting investor insight.

PoseDel Rhea J sells 13,998 Aehr Test Systems shares at $30.02—an ordinary portfolio move, not a warning, amid AI‑chip contract gains and market rally.

Insider sale by Aehr Test Systems’ director Laura Oliphant raises warning flags as the company faces negative earnings and high volatility—investors should watch closely.